Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The efficacy and safety of diode laser cycloablation in the treatment of refractory glaucoma in a South African population

Thesis (MMed)--Stellenbosch University, 2022.

Saved in:
Bibliographic Details
Main Author: Thomas, Jason Peter
Other Authors: Smit, Derrick
Format: Thesis
Language:en_ZA
Published: Stellenbosch : Stellenbosch University 2022
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613990291505152
access_status_str Open Access
author Thomas, Jason Peter
author2 Smit, Derrick
author_browse Smit, Derrick
Thomas, Jason Peter
author_facet Smit, Derrick
Thomas, Jason Peter
author_sort Thomas, Jason Peter
collection Thesis
dc_rights_str_mv Stellenbosch University
description Thesis (MMed)--Stellenbosch University, 2022.
format Thesis
id oai:scholar.sun.ac.za:10019.1/124765
institution Stellenbosch University (South Africa)
language en_ZA
last_indexed 2026-06-10T12:44:55.028Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository
publishDate 2022
publishDateRange 2022
publishDateSort 2022
publisher Stellenbosch : Stellenbosch University
publisherStr Stellenbosch : Stellenbosch University
record_format dspace
source_str SUNScholar — Stellenbosch University Repository
spelling oai:scholar.sun.ac.za:10019.1/124765 The efficacy and safety of diode laser cycloablation in the treatment of refractory glaucoma in a South African population Thomas, Jason Peter Smit, Derrick Stellenbosch University. Faculty of Medicine and Health Sciences. Dept. of Ophthalmology Glaucoma--Treatment Intraocular pressure People with visual disabilities Glaucoma -- Surgery Thesis (MMed)--Stellenbosch University, 2022. ENGLISH SUMMARY: The development of a safe and effective protocol for trans-scleral cyclophotocoagulation in a Southern African population presenting with refractory glaucoma to a tertiary eye care centre. prospective, non-randomised, observational study of patients attending the Eye Clinic at Tygerberg Hospital, Cape Town, South Africa between March 2018 and January 2020. 119 eyes of 105 eligible patients were treated during the study period. The mean laser power was 1766 ± 187 milliwatt per burn for a mean of 15.6 ± 2.9 burns per eye. Mean total delivered energy per eye was 55.28 ± 12.61 Joule. 64% of the patients who followed up for the entire six-month period had an intraocular pressure reduction of ≥ 30% and 42.2% of those followed up had an IOP of ≤ 22 mmHg. The pain scores reported by patients decreased significantly between pre-operatively and three months (coefficient -1.752, p<0.001) and between pre-operatively and six months (coefficient -1.498, p=0.002). There was not a statistically significant effect on the change in topical medication from pre-operatively to three months (coefficient = -0.089, p=0.186), nor from pre-operatively to six months (coefficient = -0.003, p=0.946). Oral acetazolamide use decreased from 50.4% of patients at the date of their initial cyclophotocoagulation treatment to 9.3% at three months and further to 7.8% at six months. One eye had a scleral perforation at the time of initial treatment; no further complications arose. An individualized, “pop-titrated” cyclophotocoagulation protocol is safe and effective for use in a Southern African population. Retreatment should be considered at three months if intraocular pressure is not adequately controlled. AFRIKAANS OPSOMMING: Die ontwikkeling van ‘n veilige en effektiewe protokol vir trans-sklerale siklofotokoagulasie in ‘n Suider-Afrikaanse bevolking wat presenteer met onbeheerde gloukoom by ‘n tersiêre oogsorgsentrum. ‘n Prospektiewe, nie-gerandomiseerde, observasionele studie van pasiënte by die Tygerberg Hospitaal oogkliniek, Kaapstad, Suid-Afrika tussen Maart 2018 en Januarie 2020. 119 oë van 105 pasiënte was behandel gedurende die studieperiode. Die gemiddelde laser-energie was 1766 ± 187 milliwatt per laseraanwending vir ‘n gemiddeld van 15.6 ± 2.9 aanwendings per oog. Die gemiddelde energie toegepas per oog was 55.28 ± 12.61 Joule. 64% van pasiënte wie opgevolg het vir die ses-maand periode het ‘n intraokulêre druk verlaging van ≥ 30% en 42.2% van diegene het ‘n drukverlaging tot ≤ 22 mmHg gehad. Die pyntellings gerapporteer deur pasiënte het noemenswaardig verminder van pre-operatief en drie maande (koëffisiënt -1.752, p<0.001) en tussen pre-operatief en ses maande (koëffisiënt -1.498, p=0.002). Daar was nie ‘n statisties beduidende verandering in die gebruik van topikale medikasies tussen pre-operatief en drie maande (koëffisiënt = -0.089, p=0.186) of ses maande nie (koëffisiënt = -0.003, p=0.946). Orale asetazolamied verbruik het verminder vanaf ‘n vlak van 50.4% van pasiënte by aanvanklike behandelingsdatum tot 9.3% op drie maande en verder tot 7.8% op ses maande. Een oog het ‘n sklerale perforasie ontwikkel na laserbehandeling maar geen verdere komplikasies is gedokumenteer nie. Masters 2022-03-08T08:28:21Z 2022-04-29T09:31:25Z 2022-03-08T08:28:21Z 2022-04-29T09:31:25Z 2022-04 Masters http://hdl.handle.net/10019.1/124765 en_ZA Stellenbosch University 30 pages : illustrations application/pdf Stellenbosch : Stellenbosch University
spellingShingle Glaucoma--Treatment
Intraocular pressure
People with visual disabilities
Glaucoma -- Surgery
Thomas, Jason Peter
The efficacy and safety of diode laser cycloablation in the treatment of refractory glaucoma in a South African population
thesis_degree_str Master's
title The efficacy and safety of diode laser cycloablation in the treatment of refractory glaucoma in a South African population
title_full The efficacy and safety of diode laser cycloablation in the treatment of refractory glaucoma in a South African population
title_fullStr The efficacy and safety of diode laser cycloablation in the treatment of refractory glaucoma in a South African population
title_full_unstemmed The efficacy and safety of diode laser cycloablation in the treatment of refractory glaucoma in a South African population
title_short The efficacy and safety of diode laser cycloablation in the treatment of refractory glaucoma in a South African population
title_sort efficacy and safety of diode laser cycloablation in the treatment of refractory glaucoma in a south african population
topic Glaucoma--Treatment
Intraocular pressure
People with visual disabilities
Glaucoma -- Surgery
url http://hdl.handle.net/10019.1/124765
work_keys_str_mv AT thomasjasonpeter theefficacyandsafetyofdiodelasercycloablationinthetreatmentofrefractoryglaucomainasouthafricanpopulation
AT thomasjasonpeter efficacyandsafetyofdiodelasercycloablationinthetreatmentofrefractoryglaucomainasouthafricanpopulation